Ultragenyx Pharmaceutical, Inc. (RARE)
21.46
-0.34
(-1.56%)
USD |
NASDAQ |
Mar 05, 16:00
21.47
+0.01
(+0.05%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Free Cash Flow : -487.00M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 141.78M |
| Johnson & Johnson | 19.70B |
| CorMedix, Inc. | -- |
| Apellis Pharmaceuticals, Inc. | 45.01M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -99.83M |
| Cash from Investing (Quarterly) | -72.25M |
| Cash from Financing (Quarterly) | 394.19M |
| Free Cash Flow Per Share (Quarterly) | -1.009 |
| Free Cash Flow to Equity (Quarterly) | -489.65M |
| Free Cash Flow to Firm (Quarterly) | -81.62M |
| Free Cash Flow Yield | -23.01% |